Ad is loading...
BRXAX
Price
$13.72
Change
-$0.06 (-0.44%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

BRXAX vs VTSNX

Header iconBRXAX vs VTSNX Comparison
Open Charts BRXAX vs VTSNXBanner chart's image
MFS Blended Research Intl Eq A
Price$13.72
Change-$0.06 (-0.44%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
BRXAX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRXAX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXAX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. BRXAX (719M). VTSNX pays higher dividends than BRXAX: VTSNX (3.29) vs BRXAX (2.39). BRXAX was incepted earlier than VTSNX: BRXAX (9 years) vs VTSNX (14 years). BRXAX is a more actively managed with annual turnover of: 56.00 vs. VTSNX (4.00). BRXAX has a lower initial minimum investment than VTSNX: BRXAX (1000) vs VTSNX (5000000). BRXAX annual gain was more profitable for investors over the last year : 19.59 vs. VTSNX (10.92). BRXAX return over 5 years is better than : 31.96 vs. VTSNX (15.91).
BRXAXVTSNXBRXAX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years14 years-
Gain YTD11.9094.535263%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets719M442B0%
Annual Yield % from dividends2.393.2973%
Returns for 1 year19.5910.92179%
Returns for 3 years2.94-5.86-50%
Returns for 5 years31.9615.91201%
Returns for 10 yearsN/A29.81-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals